Thompson Davis & Co., Inc. Gsk PLC Transaction History

Thompson Davis & Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $38,880 - $45,310	-1,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $14,906 - $16,008	375 Added 60.0%	1,000 $40,000
Q2 2018 Aug 03, 2018	SELL	$39.61 - $42.76 $9,902 - $10,690	-250 Reduced 28.57%	625 $25,000
Q1 2018 May 02, 2018	BUY	$36.18 - $40.15 $4,522 - $5,018	125 Added 16.67%	875 $34,000
Q4 2017 Feb 05, 2018	SELL	$35.34 - $41.9 $25,798 - $30,587	-730 Reduced 49.32%	750 $27,000
Q3 2017 Oct 30, 2017	SELL	$39.44 - $41.55 $1,577 - $1,662	-40 Reduced 2.63%	1,480 $60,000
Q2 2017 Aug 10, 2017	BUY	N/A	1,520	1,520 $66,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.